Open AccessMicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction
Author(s) -
Eric Rytkin,
К. Б. Мирзаев,
Irina V. Bure,
К. А. Акмалова,
Sherzod Abdullaev,
А. А. Качанова,
В. В. Смирнов,
Elena A. Grishina,
Nataliya Lyakhova,
Elena Aleshkovich,
Anna Saribekian,
Д. А. Андреев,
А. В. Шабунин,
Д. А. Сычев
Publication year - 2021
Publication title -
pharmacogenomics and personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 28
ISSN - 1178-7066
DOI - 10.2147/pgpm.s324612
Subject(s) - medicine , p2y12 , ticagrelor , clopidogrel , microrna , cyp2c19 , percutaneous coronary intervention , biomarker , acute coronary syndrome , myocardial infarction , gene , biochemistry , chemistry , cytochrome p450 , metabolism
The aim of this study is to assess 6 micro-RNAs: miR-126, miR-223, miR-150, miR-29, miR-34, miR-142 as potential biomarkers for P2Y12- inhibitors resistance prediction.